Brain and Spine Tumor Center
Brain and Spine Tumor Center Team
Ziya L. Gokaslan, MD, FAANS, FACS, serves as the chief of neurosurgery at Rhode Island and The Miriam hospitals, director of the Comprehensive Spine Center at Rhode Island Hospital, and clinical director of the Norman Prince Neurosciences Institute. In addition, Dr. Gokaslan is the Gus Stoll Professor of Neurosurgery, chair of the department of neurosurgery, and director of the Complex Spinal Surgery Fellowship at The Warren Alpert Medical School of Brown University.
Gokaslan earned his medical degree from the University of Istanbul in Turkey. He completed an internship in general surgery, a fellowship in neurotraumatology, a residency in neurosurgery at Baylor College of Medicine in Houston, and a fellowship in clinical spinal surgery at New York University Medical Center. He is a recipient of numerous prestigious awards and an active member of several professional societies.
Gokaslan comes to Lifespan from Johns Hopkins in Baltimore, where he was vice chairman of the department of neurosurgery, director of the neurosurgical spine program, and director of the neurosurgical spine metastasis center, as well as professor of neurology, oncology, and orthopedic surgery at Johns Hopkins University School of Medicine. His practice focuses on complex spinal reconstruction and radical surgical treatment of both primary and metastatic spinal tumors, sacral neoplasms, and spinal cord tumors.
Steven A. Toms, MD, is a board-certified neurosurgeon and vice chair for the department of neurosurgery at Rhode Island Hospital. He is a professor of neurosurgery, medicine and health services, policy and practice at The Warren Alpert Medical School of Brown University. He has been the principal investigator of both basic and clinical research studies, including studies on the development of therapeutic approaches for primary brain tumors and cancer metastasis to the brain.
He is the director of the brain tumor program for Lifespan Health Systems and is jointly responsible for the Gamma Knife and Cyberknife units with radiation oncology. Dr. Toms has been published in more than 80 medical journals and multiple book chapters. He has edited one book and served as editor and reviewer for a number of publications. He is a member of the American Association of Neurological Surgeons, the Congress of Neurological Surgeons and the Society for Neuro-Oncology.
Adetokunbo Oyelese, MD, PhD, FAANS is the director of the spinal surgery division and the surgical director for the Comprehensive Spine Center at Rhode Island Hospital. He is board certified by The American Board of Neurological Surgery and specializes in complex spinal disorders. He is an associate professor in the Department of Neurosurgery and the assistant program director of the neurosurgery residency program at The Warren Alpert Medical School of Brown University. His research interests lie in understanding repair and plasticity within the spine and spinal cord.
His practice includes patients with trauma to the spine. He also has a special interest in the management and treatment of complex degenerative diseases of the spine, including spinal stenosis, degenerative disc disease, and spinal deformity, as well as treatment of tumors arising from the spine and spinal cord. He offers patients cutting-edge surgical techniques such as minimally invasive spine surgery, artificial disc replacement surgery and Cyberknife stereotactic radiosurgery for tumors involving the spine and spinal cord.
Dr. Oyelese earned his medical and doctoral degrees from Yale University School of Medicine, where he was elected to the Alpha Omega Alpha (AOA) honor medical society. He completed his residency in neurosurgery at Stanford University and fellowship training at the Cedars-Sinai Institute for Spinal Disorders.
Deus Cielo, MD received his medical degree from the Brown-Dartmouth Medical Program of Dartmouth Medical School and Brown Medical School. He remained at Brown where he completed his internship in general surgery, as well as his residency training in neurological surgery.
After completion of his training, he joined the department of neurosurgery at The Warren Alpert Medical School of Brown University where he is an assistant professor.
Dr. Cielo is board certified by the American Board of Neurological Surgery and specializes in adult general neurosurgery. He is also a member of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons.
Curtis Doberstein, MD is the director of cerebrovascular and skull-base surgery at Rhode Island Hospital and executive vice-chair of clinical operations. In addition, Dr. Doberstein is director of the Neurosurgery Residency Program and professor of neurosurgery at The Warren Alpert Medical School of Brown University. Dr. Doberstein received his medical degree in 1988 from McGill University in Montreal and completed his residency in neurosurgery and fellowship at the University of California at Los Angeles.
Dr. Doberstein has been board-certified by the American Board of Neurosurgery since 2000. He served as interim chairman of neurosurgery at the Warren Alpert Medical School of Brown University from 2007 to 2010. In 1995, Dr. Doberstein joined the Neurosurgery Foundation and the Warren Alpert Medical School of Brown University. He is an associate professor (clinical) in the department of neurosurgery at Brown and serves as the Brown University neurosurgery residency program director. He directs the section of vascular neurosurgery at Rhode Island Hospital. He is an active member of the American Association of Neurological Surgeons and Congress of Neurologic Surgeons and serves as a MOC/CME committee member for the American Association of Neurological Surgeons.
Dr. Doberstein specializes in surgery on the blood vessels of the brain, neck and spinal column. He sees many patients with circulatory problems such as aneurysms, arteriovenous malformations and carotid artery disease. He also treats patients with nervous system tumors, including those of the brain and the skull base. Patients with degenerative spine disorders comprise another large part of his practice.
Dr. Doberstein, MD has conducted research on apoptosis after stroke and cerebral metabolic alterations following closed head injuries.
At present, he is investigating clinical outcomes following the removal of plaque from a carotid artery. He has performed more than 500 of these surgeries. Specifically, he is exploring the feasibility of same-day discharge after carotid endarterectomry.
- Group B Beta-Hemolytic Osteomyelitis of the Heel: A Case Report. Doberstein C, MacEwen GD, Lee MS Clin Orthop 213:225-228 1988
- Intraoperative Angiography in Cerebrovascular Surgery. Martin NA, Doberstein C, Bentson J, Vinuela F, Dion J, Becker DP Clin Neurosurg 37:312-331 1990
- Cystic Neoplasms of the Pancreas. Doberstein C, Kirchner R, Gordon L, Morgenstern L, Shapiro S Mt. Sinai J.Med 57:102-106 1990
- Post-traumatic Cerebral Arterial Spasm: Transcranial Doppler Ultrasound, Cerebral Blood Flow, and Angiographic Findings. Martin NA, Doberstein C, Caron M, Zane C, Thomas K, Becker DP J. Neurosurg, 77:575-583 1992
- Clinical Considerations in the Doberstein C, Hovda DA, Becker DB Ann Emerg Med, 22:993-997 1993
- Metabolic Alterations Accompany Ionic Disturbances and Cellular Doberstein C, Fineman I, Hovda DA, Martin NA, Keenly L, Becker DP Acta Neurochir (Suppl)60:41-44 1994
- Cerebral Blood Flow Measurement in Martin NA, Doberstein C Neurosurg Clin N. Amer, 5(4):607-618 1994
- Post-traumatic Cerebral Arterial Spasm Martin NA, Doberstein C, Alexander MJ, Khanna R, Benzalcazar H, Alsina G, Zane C, McBride D, Kelly D, Houda D, Becker DB, McArthur D, Zavcha K J Neurotrauma, 12(5): 897-901 1995
- Temporally Associated Rupture of Guglielmo MA, Doberstein C A Case Report. J.1998
- The temporal Profile and Morphologic Features of Neuronal Death in Human Stroke Resemble Those Observed in Experimental Forebrain Ischemia: The Potential Role of Apoptosis. Guglielmo MA, Chan PT, Cortez S, Stopa E, McMillan P, Johanson CE, Epstein M, Doberstein CE Neurol Res 20:289-296 1998
- Therapeutic Embolization Arteriovenous Malformations: The Case For and Against Martin N, Khanna R, Doberstein C, Benston J. Clinical Neurosurgery, Vol. 46, 295-318 1998
- Assessment of the Value of MR Imaging for Examining Patients with Angiographically Negative Subarachnoid Hemorrhage Rogg JM, Smeaton S, Doberstein C, Goldstein JH, Tung GA, Haas RA AJR 172:201-206 1999
- Intracanalicular Aneurysm of the Anterior Inferior Cerebellar Artery Revealed by Multi- Detector CT Angiography. Jayaraman MV, Mayo-Smith WW, Doberstein CE AJR Am J Neuroradiol 24(7): 1338-40 2003
- Recovery of choroid plexus function in aged rats subjected to transient forebrain ischemia Johanson C, Palm D, Doberstein C, Stopa E Neurosci. Lett., in press.
- Sustained CA1 Neuronal Survival by FGF-Z Following Forebrain Ischemia In The Rat: A Possible Role For The Choroid Plexus-CSF System. Hayamizv T, Chan PT, Doberstein C, Sunwoo L, Guglielmo MA, Hayamizv T, Chan PT, Doberstein C, Sunwoo L, Guglielmo MA, Hayamizv T, Chan PT, Doberstein C, Sunwoo L, Guglielmo MA, Johanson, CE. Neurological Research
- Spontaneous thrombosis of a cerebral arteriovenous malformation: A case report. Sungarian A, Doberstein C, Haas R Scandinavian J. Nsurg.
Albert Telfeian, MD, PhD, leads the endoscopic spine surgery program. A world-renown leader in endoscopic spinal surgery with national and international patient referral base, has been also appointed as the Director of newly established Center for Minimally Invasive Endoscopic Spinal Surgery at Rhode Island Hospital/Brown University. He is board certified by The American Board of Neurological Surgery and is an Associate Professor of Neurosurgery at The Warren Alpert School of Medicine at Brown University. Previously he was an assistant professor of neurosurgery at Children’s Hospital of Philadelphia and associate professor of neurosurgery at Texas Tech University Health Sciences Center.
Dr. Telfeian also serves as Vice Chair for Quality Improvement to improve the quality of care for patients.
He is a graduate of the MD/PhD program at The Warren Alpert Medical School of Brown University and completed a postdoctoral fellowship at Yale University and his neurosurgical residency at the Hospital of the University of Pennsylvania. He also completed fellowship training in spine and functional epilepsy surgery at Switzerland’s Centre Hospitalier Universitaire Vaudois and a pediatric neurosurgery fellowship at Children’s Hospital of Philadelphia.
Dr. Telfeian has published extensively in the areas of epilepsy, functional and spine surgery and is currently involved in the research and development of ultra-minimally invasive endoscopic techniques. He was the recipient of the American Association of Neurologic Surgeons Stereotactic and Functional Neurosurgery Research Award, the American Epilepsy Society Young Investigator Award, and the J. Kiffin Penry Pediatric Epilepsy Award, and was named one of the nation’s 15 leaders in neurosurgery in the October 2011 edition of Newsweek.
- Smith SE, Kirkham FJ, , Deveber G, Millman G, Dirks PB, Wirrell E, Telfeian AE, Sykes K, Barow K, Ichord R.Outcome following decompressive craniectomy for malignant middle cerebral artery infarction in children. Dev Med Child Neurol 2010 Aug 30.
- Simon SL, Auerbach JD, Garg S, Sutton L, Telfeian AE, Dormans JP. Efficacy of spinal instrumentation and fusion in the prevention of postlaminectomy spinal deformity in children with intramedullary spinal cord tumors. J Pediatr Orthop 2008 vol 28, No. 2.
- Porter BE, Zhang G, Celix J, Hsu FC, Raol YH, Telfeian AE, Gallagher PR, Coulter DA, Brooks-Kayal AR.Heterogeneous GABAA receptor subunit expression in pediatric epilepsy patients. Neurobiol Dis 2005 Apr;18(3):484-91.
- Sestokas AK, Telfeian AE, Duhaime AC, Sutton L, Sestokas LO, Schwartz DM.Intraoperative motor cortex mapping in children with intractable seizures using motor evoked potential (MEP) threshold gradients. J Clin Neurophys 2005 Oct;22(5).
- Telfeian AE, Judkins A, Younkin D, Pollock AN, Crino P. Subependymal giant cell astrocytoma with cranial and spinal metastases in a patient with tuberous sclerosis. Journal of Neurosurgery (Pediatrics 5) 2004;100:498-501.
- Telfeian AE, Landa J, Drummond D. Congenital formation of an intraspinal osseous vertebral ring causing spinal cord compression. Spine 2004 Jan;29(1):E1-3.
Petra Klinge, MD is an internationally renowned general neurosurgeon specializing in the surgical treatment of patients with brain tumors, hydrocephalus and Alzheimer’s disease, pediatric diseases and treatment of congenital diseases like Chiari and spinal malformations.
Dr. Klinge is a professor of neurosurgery at The Warren Alpert School of Medicine at Brown University. Prior to this, she was professor of neurosurgery at the Medical School Hannover, Germany. She received her medical degree at the University of Kiel in 1993 and completed her neurosurgical residency at Hannover Medical School in Germany in 2002. She was senior associate professor of neurosurgery at the International Neuroscience Institute in Hannover, Germany, where she had the opportunity to be educated by Professor M. Samii, a founder of modern skull base surgery.
Dr. Klinge is an active member of the American Association of Neurosurgeons and the Congress of Neurological Surgeons. She is editor in chief of the Elsevier journal Interdisciplinary Neurosurgery: Advanced Techniques and Case Management (INAT) and associate editor of Clinical Neurology and Neurosurgery (CNN). She also serves as reviewer for international scientific journals including Neurosurgery, Journal of Neurosurgery, Journal of Neurology, Neurosurgery & Psychiatry and others. She is past president of the International Society for Hydrocephalus and CSF disorders.
Dr. Klinge’s scientific interests comprise the development of advanced techniques for diagnosing and treatment of dementia, experimental work to advance the understanding of normal aging and dementia and to develop novel biotechnical treatment approaches including stem cell therapy. Her scientific publications are listed by the US National Library of Medicine.
- Multiplicity of Cerebrospinal Fluid Functions: New Challenges in Health and Disease Conrad E. Johanson; John A. Duncan; Petra M. Klinge; Edward G. Stopa and Gerald PD. Silverberg. Cerebrospinal Fluid Research 2008
- Modified calcium accumulation after controlled cortical impact under cyclosporin A treatment: a (45)Ca autoradiographic study. Mirzayan MJ; Klinge PM; Ude S; Hotop A; Samii M; Brinker T; Korkmaz Z; Meyer GJ; Knapp WH; Samii A. Neurol Res. 2008
- Correlates of local cerebral blood flow (CBF) in normal pressure hydrocephalus patients before and after shunting-A retrospective analysis of [(15)O]H(2)O PET-CBF studies in 65 patients. Klinge PM; Brooks DJ; Samii A; Weckesser E; van den Hoff J; Fricke H; Brinker T; Knapp WH; Berding G. Clinical Neurol Neurosurg 2008
- A positron emission tomography study of cerebrovascular reserve before and after shunt surgery in patients with idiopathic chronic hydrocephalus. Klinge PM; Berding G; Brinker T; Knapp WH; Samii M. J Neurosurg. 1999 Oct; 91(4): 605-9.
- Outcome of shunting in idiopathic normal-pressure hydrocephalus and the value of outcome assessment in shunted patients. Klinge P; Marmarou A; Bergsneider M; Relkin N; Black PM. Neurosurgery. 2005 Sep; 57 (3 Suppl):S40-52
- Correlates of local cerebral blood flow (CBF) in normal pressure hydrocephalus patients before and after shunting-A retrospective analysis of [(15)O]H(2)O PET-CBF studies in 65 patients. Klinge PM; Brooks DJ; Samii A; Weckesser E; van den Hoff J; Fricke H; Brinker T; Knapp WH; Berding G. Clinical Neurol Neurosurg 2008
- Amyloid and Tau accumulate in the brains of aged hydrocephalic rats. Gerald D. Silverberg, Miles C. Miller, Jason T. Machan, Conrad E. Johanson, Ilias N. Caralopoulos, Crissey L. Pascale, Anna Heile, Petra M. Klinge. BRAIN RESEARCH 1317 (2010) 286 – 296
Jared Fridley, MD, is a neurosurgeon subspecializing in complex spinal surgery. He is an assistant professor and director of the Spine Surgery Outcomes Research Laboratory at The Warren Alpert Medical School of Brown University.
Dr. Fridley’s work has been published in many peer-reviewed articles and book chapters. He is a member of the Congress of Neurological Surgeons and the American Academy of Neurologic Surgeons. His clinical interests include degenerative spinal disease, spinal trauma, tumors and deformities, and peripheral nerve surgery. His research interests include spinal surgery outcomes and spinal cord injury.
Wael Asaad, MD, PhD received his undergraduate degree from Amherst College in 1993, then earned a PhD in systems neuroscience from Massachusetts Institute of Technology in 2001, and his MD from Yale University in 2003. Asaad completed a general surgery internship and neurosurgical residency at the Massachusetts General Hospital. During his residency, he undertook additional training in functional neurosurgery. In 2011, he joined the department of neurosurgery at The Warren Alpert Medical School of Brown University.
Asaad's clinical interests include functional neurosurgery for movement disorders and psychiatric disease, traumatic brain injury, and general neurosurgery of the brain and spine.
His basic science interests focus on the ways in which neuronal circuits in the frontal cortex and basal ganglia underlie visual-motor learning, memory and decision-making, and how a better understanding of these might lead to strategies to alleviate the cognitive aspects of psychiatric and neurological diseases, including traumatic brain injury and stroke.
Konstantina Svokos, DO, is a neurosurgeon who specializes in pediatric neurosurgery. She has done both clinical and molecular research throughout her training and her work has been published in several peer-reviewed journals and book chapters.
Dr. Svokos is fluent in English, Greek and Spanish. She is a member of the Society for Neuro Oncology, the American College of Osteopathic Surgeons, the Congress of Neurological Surgeons and the American Association of Neurological Surgeons.
Heinrich Elinzano, MD is an adult neurologist, with subspecialty training in neuro-oncology and spinal cord injury medicine, and is also an assistant professor of neurology at The Warren Alpert Medical School of Brown University. He is experienced in the management of tumors of the central nervous system and has a particular interest in conducting clinical trials for the treatment of primary brain tumors and the neurological complications of systemic cancer.
Elinzano completed his neurology residency at St. Vincent Hospital and Medical Center of New York, his spinal cord injury medicine fellowship training at Barnes-Jewish Hospital at Washington University Medical Center in St. Louis, Missouri, and his neuro-oncology fellowship training at The Johns Hopkins University School of Medicine in Baltimore and The Neuro-Oncology Branch of the U.S. National Institutes of Health's National Cancer Institute and National Institute of Neurologic Diseases and Stroke. Prior to his current position at Rhode Island Hospital, he was an adult neuro-oncologist at the Cleveland Clinic Brain Tumor and Neuro-Oncology Center.
Howard P. Safran, MD is the chief of hematology/oncology at the Lifespan Cancer Institute at Rhode Island, The Miriam and Newport hospitals, and the medical director for the Brown University Oncology Group. Safran is a professor of medicine at The Warren Alpert Medical School of Brown University and a nationally recognized leader in the development of new treatments for upper GI cancers. He is a member of the U.S. National Cancer Institute's pancreatic and gastrointestinal cancer task forces.
Ariel Birnbaum, MD, is a medical oncologist at Rhode Island Hospital. He received his medical degree from the Medical College of Ohio, completed his residency training at the University of Minnesota hospitals, and completed his fellowship in hematology/oncology at The Warren Alpert Medical School of Brown University. His clinical interests include combined modality treatment for lung cancer and end of life care. He is a member of the American Society of Clinical oncology and a participant in the Brown University Oncology Group.
Bradley DeNardo, MD, is a board-certified pediatrician who specializes in pediatric hematology and oncology at Hasbro Children’s Hospital. He is an assistant professor of pediatrics at The Warren Alpert Medical School of Brown University. After attending The Warren Alpert Medical School, Dr. DeNardo continued dedicating his time to the medical students there by instructing them in pediatrics for the following nine years. In addition, Dr. DeNardo is a consulting physician at Women and Infants Hospital.
Dr. DeNardo’s work has been published in several peer-reviewed journals and books, and he has also presented his research at the local, regional and international levels. He is a member of a number of professional societies, including Children’s Oncology Group and the American Society of Pediatric Hematology/Oncology.
Rishi R. Lulla, MD, MS, is the chief of pediatric hematology/oncology at Hasbro Children’s Hospital and an international expert in the care of children and young adults with brain and spinal cord tumors. After completing his residency and fellowship at Northwestern University in Chicago, Dr. Lulla spent several years as an attending physician on the pediatric neuro-oncology team at Northwestern. He has recently been given the Hero Award for outstanding dedication to pediatric neuro-oncology by the Pediatric Brain Tumor Foundation, and was named one of Chicago’s Top Cancer Doctors by Chicago magazine.
Dr. Lulla’s scientific work has been published in more than 20 peer-reviewed journals and two books. He has presented his findings on pediatric central nervous system tumors at the local, national, and international levels, and he has served as principal investigator to multiple grant-sponsored research investigations. His current research activities are focused on translating laboratory findings into novel treatment for children with brain and spinal cord tumors. He served as the executive chair of the Children’s Brain Tumor Tissue Consortium and is an active member of the American Society of Pediatric Hematology Oncology, the Children’s Oncology Group, and the Society of Neuro-Oncology.
Timothy J. Kinsella, MD, is an internationally recognized radiation oncologist and a research scholar professor of radiation oncology at The Warren Alpert Medical School of Brown University. Kinsella received his undergraduate degree from St. John Fisher College in Rochester, NY; a master’s degree with honors from Brown University; and both his master of science in radiation biology and his medical degree from the University of Rochester School of Medicine in Rochester, NY. He completed his residency training in internal medicine at the Mayo Clinic, fellowship training in medical oncology at Dana Farber Cancer Institute in Boston, MA, and his residency training in radiation oncology at the Harvard Radiation Oncology Program. He was a fellow of the American Society of Therapeutic Radiology and Oncology. Kinsella has been editor-in-chief of Frontiers in Radiation Oncology and editorial board member of eight other journals. He is board certified in internal medicine, medical oncology and radiation oncology. His areas of clinical expertise include the treatment of bone and soft tissue sarcomas, brain tumors, lymphomas, gastrointestinal cancers and pediatric cancers. He has laboratory expertise in the development of intraoperative radiotherapy, radiation sensitizing drugs and small molecules that modify DNA repair processing of radiation damage.
Jaroslaw T. Hepel, MD, serves as director of stereotactic radiosurgery at Rhode Island Hospital and as an assistant professor at The Warren Alpert Medical School of Brown University. He also serves as associate director of the Tufts-Affiliated Hospitals Residency Training Program in Radiation Oncology. He is board certified in radiation oncology by the American Board of Radiology. Hepel received his undergraduate degree at Cornell University and earned his medical degree at the University of Rochester. He completed internal medicine residency at the University of California Irvine Medical Center, and then went on to complete residency in the specialty of radiation oncology at Tufts Medical Center in Boston, MA.
Hepel has broad experience and knowledge, and is active in caring for patients with a wide range of malignant diseases. However, he holds a particular interest and clinical expertise in the treatment of breast cancer and in stereotactic radiosurgery/radiotherapy for diseases involving the lung, brain, spine, liver and other sites. He is not only very active in the clinic but also has a keen academic interest in these areas. He has published several book chapters and multiple scientific papers, and has regularly presented his work at national meetings. Through his academic work, he strives to improve treatment outcomes for patients not only in regard to achieving higher cure rates but also to minimizing treatment side effects.
David Wazer, MD, is director of the Lifespan Cancer Institute of Rhode Island, The Miriam and Newport hospitals as well as radiation oncologist-in-chief at Rhode Island Hospital. He is professor and chairman of the departments of radiation oncology at both The Warren Alpert Medical School of Brown University and Tufts University School of Medicine.
Dr. Wazer is an internationally recognized expert in the application of new technology in the field of radiation oncology. He has published more than 200 scientific articles, written several books, and is also editor-in-chief of the American Journal of Clinical Oncology. Wazer earned his medical degree (with honors) from the New York University School of Medicine, New York, NY, and also completed a research fellowship in neurochemistry at New York University. Dr. Wazer obtained his clinical training in internal medicine at Brown University and in radiation oncology at Tufts University. His clinical research interests include the study of the efficacy, toxicity, and cost/utility analysis of image-guided radiation therapy, partial breast irradiation, electronic brachytherapy and hyperthermia. He is actively involved in the development of clinical trials for cancers of the breast, skin, gastrointestinal tract and lung.
Dr. Wazer is a fellow of the American Society for Radiation Oncology and the American College of Radiation Oncology and a member of the Radiation Research Society, American Society of Clinical Oncology, the American College of Radiology, the American Radium Society, the American Association for the Advancement of Science and the American Brachytherapy Society.
Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor.
DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.
Esther Yu, MD, is a radiation oncologist at Rhode Island Hospital. A 2012 graduate of Emory University School of Medicine, Dr. Yu has published her research on breast, central nervous system, and gastrointestinal cancers in many medical journals, and has presented at several national meetings for radiation oncology. She was named chief resident during her final year of residency at Tufts Medical Center in 2016-2017.
Dr. Yu is a winner of the American Brachytherapy Society’s 2016 HDR Scholarship Award. She holds a number of professional memberships including the American Society for Radiation Oncology and the American College of Radiation Oncology.
Douglas C. Anthony, MD, PhD is chief of pathology at Rhode Island and The Miriam hospitals.
Anthony served as chair of the department of pathology and anatomical sciences and professor of neurology at the University of Missouri. At the University of Missouri Health Care he served as chief of pathology and medical director of pathology clinical laboratories. He also served as a pathologist at the Harry S. Truman Veterans Administration Medical Center, Women and Children's Hospital, and the Ellis Fischel Cancer Center, and as a neuropathologist for the Office of the Medical Examiner in Boone, Callaway and Greene counties in Missouri. Previously, he was on the faculty at Harvard Medical School and served as a neuropathologist at Boston Children's Hospital, Brigham and Women's Hospital, and as a neuropathologist consultant to the Office of the Chief Medical Examiner for the Commonwealth of Massachusetts.
Anthony earned his bachelor's degree in chemical engineering from Washington University in St. Louis, Mo.; his doctoral degree in experimental pathology from Duke University; and his medical degree from Duke University. He completed his residency in pathology and a fellowship in neuropathology at Duke University Medical Center.
He is a member of the United States and Canadian Academy of Pathology; the American Association of Neuropathologists; the College of American Pathologists; the Society for Neuroscience; Society of Toxicology; and the American Society for Neurochemistry, among others. He has served on several editorial boards, including the Journal of Neuropathology and Experimental Neurology; Advances in Anatomic Pathology; and Pediatric Pathology and Molecular Medicine, and is an author of the neuroscience sections of Robbins and Cotran Pathologic Basis of Disease. He has won numerous awards, including the Dr. Edison H. and Sallie Y. Miyawaki Teaching Award in Neurosciences at Harvard Medical School; the Excellence in Education Award in pre-clinical sciences at the University of Missouri; and the Order of Socrates award at the School of Medicine at the University of Missouri.
Anthony's research interests include the biology of axons and its relevance to diseases of peripheral nerves, and the pathobiology of brain tumors.
Jesse L. Hart, DO, specializes in pathology at Rhode Island Hospital, and serves as director of immunohistochemistry for Lifespan Laboratories. He has taught as an invited lecturer at The Warren Alpert Medical School at Brown University and at the University of Rhode Island. He has given many lectures at the hospital during the microscopic slide conferences, and received the Golden Apple Award for Excellence in Teaching for his dedication and skill in the field.
Dr. Hart is also an author in several original publications and peer-reviewed journals. He is an active member of the Rhode Island Society of Pathologists and the College of American Pathologists.
Jeffrey M. Rogg, MD, is director of neuroradiology and medical director of magnetic resonance imaging at Rhode Island Hospital. He is also an associate professor of diagnostic imaging at The Warren Alpert Medical School of Brown University, where he teaches cross-sectional imaging and neuroradiology. Dr. Rogg has been named as a featured “Best Doctor” by Rhode Island Monthly eight times.
Dr. Rogg has received many grants to pursue innovations in the medical field; he was the principal investigator of a study on concussions in athletes and an experiment concerning Gadovist safety and efficacy. In addition, his work has been published in several peer-reviewed journals and other publications. He is currently a member of the board of directors for the American Board for Magnetic Resonance Imaging Safety and a senior member of the American Society of Neuroradiology.
Jerrold L. Boxerman, MD, PhD, FACR, specializes in diagnostic neuroradiology at Rhode Island Hospital. He is both a guest lecturer and associate professor of diagnostic imaging at The Warren Alpert Medical School of Brown University. He serves as medical director of the MRI Research Facility at Brown University, which is affiliated with the university's Institute for Brain Science. Dr. Boxerman is also co-chair for neuroradiology for the radiology committee of the Brown University Oncology Group, and is a fellow of the American College of Radiology.
Dr. Boxerman’s published work includes more than 50 peer-reviewed papers and seven book chapters, and he currently serves as a reviewer for multiple academic radiology journals. His research focus includes perfusion-weighted MRI for characterizing and determining the treatment response of brain tumors. Dr. Boxerman is a senior member of the American Society of Neuroradiology and holds a certificate of additional qualification in neuroradiology. He frequently provides neuroradiology expertise at clinical conferences at Rhode Island Hospital.
Richard A. Haas, MD, a neuroradiologist at Rhode Island Hospital, is board certified in diagnostic radiology, neuroradiology, and vascular and interventional radiology. He is an associate professor of diagnostic radiology and neurosurgery at The Warren Alpert Medical School of Brown University, and has been teaching at the university level for many years.
Dr. Haas’s work has been published in more than 20 peer-reviewed publications. He has participated in several scientific experiments that have been displayed at various medical conferences and assemblies. He is a member of is the Radiological Society of North America and the New England Society of Cardiovascular and Interventional Radiology.
Mahesh V. Jayaraman, MD is a neuroradiologist who specializes in interventional neuroradiology at Rhode Island Hospital. He is an associate professor of diagnostic imaging, neurology and neurosurgery at The Warren Alpert Medical School of Brown University. He is also the director of the Neurovascular Center at Rhode Island Hospital.
Dr. Jayaraman’s research interest is in the minimally invasive therapy of neurovascular disease, including acute ischemic stroke. His work has been published in more than 90 peer-reviewed journals, books and book chapters. He is a senior member of the American Society of Neuroradiology and the Society of NeuroInterventional Surgery.
Ryan A. McTaggart, MD, is the director of interventional neuroradiology at Rhode Island Hospital and an assistant professor of diagnostic imaging, neurology, and neurosurgery at The Warren Alpert Medical School of Brown University.
Dr. McTaggart’s work has been published in over fifty peer-reviewed journals and he is the author of “Image-guided Ablation in the Thorax,” a chapter in a textbook about interventional oncology and cancer therapy. He has presented regionally and internationally on a variety of topics but is particularly interested in discussing improving systems of care for patients with acute stroke.
In addition to his university teaching roles, Dr. McTaggart also instructs residents and fellows in neuroradiology and diagnostic imaging at Rhode Island Hospital. He is a senior member of the Society of NeuroInterventional Surgery, American Heart Association, and the American Society of Neuroradiology. He serves on the Standards and Guidelines Committee for the Society of Neurointerventional Surgery.